Retinoic Acid Accelerates the Specification of Enteric Neural Progenitors from In-Vitro-Derived Neural Crest

Thomas J R Frith1, Antigoni Gogolou1, James O S Hackland2

  • 1University of Sheffield, Department of Biomedical Science, Sheffield, UK.

Stem Cell Reports
|August 29, 2020
PubMed

Insights

Researchers efficiently generated enteric nervous system (ENS) progenitors from human pluripotent stem cells (hPSCs). Retinoic acid is crucial for specifying these progenitors, which can form neurons and colonize the ENS, offering potential for cell therapy.

Area of Science:

  • Developmental biology
  • Stem cell biology
  • Neuroscience

Background:

  • The enteric nervous system (ENS) originates from vagal neural crest cells.
  • ENS developmental defects lead to enteric neuropathies like Hirschsprung disease.
  • Generating enteric neurons from human pluripotent stem cells (hPSCs) is crucial for disease modeling and regenerative medicine.

Purpose of the Study:

  • To efficiently generate enteric nervous system (ENS) progenitors from hPSCs.
  • To identify signals critical for early ENS progenitor specification.
  • To assess the potential of hPSC-derived ENS progenitors for therapeutic applications.

Main Methods:

  • Generation of ENS progenitors from hPSCs.
  • Assessment of retinoic acid's role in vagal axial identity and ENS progenitor specification.
  • In vitro differentiation into enteric neurons.
  • In vivo transplantation studies in adult mice.

Main Results:

  • Efficient and accelerated generation of ENS progenitors from hPSCs.
  • Retinoic acid identified as critical for vagal axial identity and ENS progenitor specification.
  • hPSC-derived ENS progenitors generated enteric neurons in vitro and successfully colonized the ENS in vivo.

Conclusions:

  • hPSC-derived ENS progenitors can be efficiently generated and specified.
  • Retinoic acid is a key signaling molecule for ENS progenitor development.
  • hPSC-derived ENS progenitors hold promise for cell therapy in enteric neuropathies.